Jazz Pharmaceuticals Schedules Shareholder Vote
Ticker: JAZZ · Form: 8-K · Filed: Jul 25, 2025 · CIK: 1232524
| Field | Detail |
|---|---|
| Company | Jazz Pharmaceuticals PLC (JAZZ) |
| Form Type | 8-K |
| Filed Date | Jul 25, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: shareholder-vote, corporate-governance
Related Tickers: JAZZ
TL;DR
Jazz Pharma calling a shareholder vote - big decisions ahead.
AI Summary
On July 24, 2025, Jazz Pharmaceuticals plc filed an 8-K report to announce a submission of matters to a vote of security holders. The filing was made public on July 25, 2025, and pertains to a meeting where shareholders will vote on important company matters. The exact nature of these matters is not detailed in this specific filing.
Why It Matters
This filing indicates that Jazz Pharmaceuticals is convening a shareholder meeting to vote on significant corporate decisions, which could impact the company's future direction and shareholder value.
Risk Assessment
Risk Level: medium — Shareholder votes can lead to significant changes in corporate governance or strategy, the outcomes of which carry inherent risks.
Key Players & Entities
- Jazz Pharmaceuticals plc (company) — Registrant
- July 24, 2025 (date) — Date of earliest event reported
- July 25, 2025 (date) — Filing date
FAQ
What is the primary purpose of this 8-K filing?
The primary purpose of this 8-K filing is to report the submission of matters to a vote of security holders.
When was the earliest event reported in this filing?
The earliest event reported in this filing was on July 24, 2025.
On what date was this 8-K filing made public?
This 8-K filing was made public on July 25, 2025.
What is the exact name of the registrant?
The exact name of the registrant is Jazz Pharmaceuticals Public Limited Company.
Where is Jazz Pharmaceuticals plc headquartered?
Jazz Pharmaceuticals plc is headquartered at Fifth Floor, Waterloo Exchange, Waterloo Road, Dublin 4, Ireland.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on July 25, 2025 regarding Jazz Pharmaceuticals plc (JAZZ).